Theresa Heggie
Director/Board Member at BIOCRYST PHARMACEUTICALS, INC.
Net worth: 324 132 $ as of 2024-03-30
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Michael Parini | M | 49 | 3 years | |
| Gerard J. Platenburg | M | 60 | 12 years | |
| Helen Thackray | M | 55 | 5 years | |
| Nancy Hutson | M | 74 | 12 years | |
| Daniel de Boer | M | 41 | 12 years | |
| George Abercrombie | M | 69 | 13 years | |
| Jeffrey Poulton | M | 56 |
Alnylam UK Ltd.
 Alnylam UK Ltd. BiotechnologyHealth Technology Founded in 2002, Alnylam UK Ltd. is a subsidiary of Alnylam Pharmaceuticals, Inc. that develops biotechnology products. The private company is based in Maidenhead, UK. | 5 years |
| Anthony Doyle | M | 44 | 4 years | |
| Jon Stonehouse | M | 63 | 17 years | |
| Ryan Arnold | M | - | 2 years | |
| Armin Reininger | M | 67 | 7 years | |
| Alane Barnes | F | 58 | 18 years | |
| James Bircher | M | 56 | 3 years | |
| Sheila Sponselee | F | - | 4 years | |
| A. Sanders | F | 60 | 2 years | |
| Margaret Hamburg | M | 68 | 5 years | |
| Steven Galson | M | 67 | 3 years | |
| James Shannon | M | 67 | 8 years | |
| Bart Filius | M | 53 | 5 years | |
| Alan Levin | M | 62 | 4 years | |
| David Ronald Jones | M | 66 |
Alnylam UK Ltd.
Alnylam UK Ltd. BiotechnologyHealth Technology Founded in 2002, Alnylam UK Ltd. is a subsidiary of Alnylam Pharmaceuticals, Inc. that develops biotechnology products. The private company is based in Maidenhead, UK.
Alnylam Germany GmbH
 Alnylam Germany GmbH BiotechnologyHealth Technology Part of Alnylam Pharmaceuticals, Inc., Alnylam Germany GmbH is a company that is leading the translation of RNA Interference (RNAi) into a completely innovative class of medicines, which they believe have the potential to transform the lives of patients with genetic and rare diseases. The private company is based in Munich, Germany. The CEOs of the company are David Ronald Jones, Hannes Schmeil, Theresa Marie Heggie. The text in the company's description is in German, but it appears to emphasize the importance of clinical trials in developing new medicines and highlights the company's use of RNAi technology to help patients with limited treatment options. | - |
| Olivier Brandicourt | M | 68 | 4 years | |
| Vin Milano Milano | M | 60 | 3 years | |
| Stephen Aselage | M | 73 | 5 years | |
| Domenico Valerio | M | 67 | 12 years | |
| Roger Davis | M | 67 |
The British United Provident Association Ltd.
 The British United Provident Association Ltd. Life/Health InsuranceFinance The British United Provident Association Ltd. provides healthcare products and services. It offers health, dental and travel insurance, optical and audiology, and care homes. The company was founded on April 3, 1947 and is headquartered in London, the United Kingdom. | 9 years |
| Amy McKee | M | 52 | 3 years | |
| Colleen Reitan | F | 64 | 6 years | |
| Timothy J. Maines | M | - | 7 years | |
| Alison Lawton | F | 62 | 10 years | |
| William P. Sheridan | M | 69 | 16 years | |
| Jinky Ang Rosselli | F | - | 9 years | |
| Andrew Morris | M | - | 5 years | |
| Philip George | M | - | 2 years | |
| Catherine Collier Kyroulis | F | - | - | |
| Daniel Rankin | M | 44 | 7 years | |
| Charles Gayer | M | 53 | 9 years | |
| Hannes Schmeil | M | - |
Alnylam Germany GmbH
Alnylam Germany GmbH BiotechnologyHealth Technology Part of Alnylam Pharmaceuticals, Inc., Alnylam Germany GmbH is a company that is leading the translation of RNA Interference (RNAi) into a completely innovative class of medicines, which they believe have the potential to transform the lives of patients with genetic and rare diseases. The private company is based in Munich, Germany. The CEOs of the company are David Ronald Jones, Hannes Schmeil, Theresa Marie Heggie. The text in the company's description is in German, but it appears to emphasize the importance of clinical trials in developing new medicines and highlights the company's use of RNAi technology to help patients with limited treatment options. | - |
| Robert Clayton Fletcher | M | 61 | 1 years | |
| Stephanie Angelini | F | - | 6 years | |
| Jurriaan Dekkers | M | - | 2 years | |
| Kelley Boucher | F | - | 5 years | |
| Sarah Kiely | F | - | 5 years | |
| Salisa Hauptmann | F | - | 3 years | |
| Ravi Rajagopal | M | 69 |
The British United Provident Association Ltd.
The British United Provident Association Ltd. Life/Health InsuranceFinance The British United Provident Association Ltd. provides healthcare products and services. It offers health, dental and travel insurance, optical and audiology, and care homes. The company was founded on April 3, 1947 and is headquartered in London, the United Kingdom. | 9 years |
| Alan Eisenberg | M | - | 7 years | |
| Søren Tulstrup | M | 59 |
Shire Human Genetic Therapies, Inc.
 Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | 12 years |
| Yarlagadda S. Babu | M | 71 | 36 years | |
| John D. Bluth | M | - | 5 years | |
| René Beukema | M | 60 | 2 years | |
| Begoña Carreño | M | 52 | 1 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Thomas Staab | M | 56 | 9 years | |
| Martin Potkins | M | 63 |
The British United Provident Association Ltd.
The British United Provident Association Ltd. Life/Health InsuranceFinance The British United Provident Association Ltd. provides healthcare products and services. It offers health, dental and travel insurance, optical and audiology, and care homes. The company was founded on April 3, 1947 and is headquartered in London, the United Kingdom. | 6 years |
| John Clarke | M | 70 | 17 years | |
| Graham Hetherington | M | 65 | 6 years | |
| James Bowling | M | 56 | 10 years | |
| Mike Mason | M | 49 | 14 years | |
| Colin Love | M | 66 | 3 years | |
| Ludovic Robin | M | - | 8 years | |
| Michael Jones | M | 54 | 13 years | |
| Clare Thompson | F | 69 |
The British United Provident Association Ltd.
The British United Provident Association Ltd. Life/Health InsuranceFinance The British United Provident Association Ltd. provides healthcare products and services. It offers health, dental and travel insurance, optical and audiology, and care homes. The company was founded on April 3, 1947 and is headquartered in London, the United Kingdom. | 7 years |
| Stephen P. Diamond | M | - | 1 years | |
| John Lorimer | M | 71 |
The British United Provident Association Ltd.
The British United Provident Association Ltd. Life/Health InsuranceFinance The British United Provident Association Ltd. provides healthcare products and services. It offers health, dental and travel insurance, optical and audiology, and care homes. The company was founded on April 3, 1947 and is headquartered in London, the United Kingdom. | - |
| Sven Håkan Björklund | M | 68 | 7 years | |
| Fred Cohen | M | 67 | 6 years | |
| Kevin Starr | M | 61 | 15 years | |
| Stanley Erck | M | 76 | 10 years | |
| Suzanne Bruhn | M | 60 |
Shire Human Genetic Therapies, Inc.
Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | 14 years |
| Kenneth Lee | M | 76 | 12 years | |
| Manmeet Singh Soni | M | 46 | 2 years | |
| George Edward Mitchell | M | 74 |
The British United Provident Association Ltd.
The British United Provident Association Ltd. Life/Health InsuranceFinance The British United Provident Association Ltd. provides healthcare products and services. It offers health, dental and travel insurance, optical and audiology, and care homes. The company was founded on April 3, 1947 and is headquartered in London, the United Kingdom. | 8 years |
| Laura Sepp-Lorenzino | M | 63 | 3 years | |
| Richard Riese | M | 61 | 2 years | |
| Andrew Komjathy | M | 61 |
Shire Human Genetic Therapies, Inc.
Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | 7 years |
| Eric Fink | M | - | 1 years | |
| Allen Hodge | M | - | 2 years | |
| Cynthia Anderson | F | 55 | 4 years | |
| Tom Luby | M | - |
Shire Human Genetic Therapies, Inc.
Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | 3 years |
| Jared Gollob | M | 60 | 11 years | |
| Tracy Zimmermann | M | 54 | 6 years | |
| Joaquín Gallego | M | - |
The British United Provident Association Ltd.
The British United Provident Association Ltd. Life/Health InsuranceFinance The British United Provident Association Ltd. provides healthcare products and services. It offers health, dental and travel insurance, optical and audiology, and care homes. The company was founded on April 3, 1947 and is headquartered in London, the United Kingdom. | 2 years |
| Masako Nakamura | F | - | 4 years | |
| Anjana Harve | F | - |
Shire Human Genetic Therapies, Inc.
Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | 2 years |
| Karen Anderson | F | 57 | 5 years | |
| Megan Sniecinski | F | 43 | 2 years | |
| Ann J. Barbier | M | 59 |
Shire Human Genetic Therapies, Inc.
Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | 4 years |
| Milan Zdravkovic | M | 54 | 4 years | |
| Julie Krop | M | 57 | 1 years | |
| Roger Adsett | M | 55 | 11 years | |
| Adi Mohanty | M | 57 | 9 years | |
| Eric Pauwels | M | 63 |
Shire Human Genetic Therapies, Inc.
Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | 5 years |
| James G. Stout | M | 58 |
Shire Human Genetic Therapies, Inc.
Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | 2 years |
| Jing Marantz | M | 59 | 2 years | |
| Rainer Kramer | M | 60 |
Shire Orphan Therapies GmbH
 Shire Orphan Therapies GmbH Pharmaceuticals: MajorHealth Technology Shire Orphan Therapies GmbH engages in the development, manufacture, and distribution of chemical and biochemical products, ingredients, as well as pharmaceutical and diagnostic products. The company was founded in 1994 and is headquartered in Berlin, Germany. | 6 years |
| Carl Ulrich Andreas de Maizière | M | 74 |
Shire Orphan Therapies GmbH
Shire Orphan Therapies GmbH Pharmaceuticals: MajorHealth Technology Shire Orphan Therapies GmbH engages in the development, manufacture, and distribution of chemical and biochemical products, ingredients, as well as pharmaceutical and diagnostic products. The company was founded in 1994 and is headquartered in Berlin, Germany. | 1 years |
| Patricia Hewitt | F | 75 |
The British United Provident Association Ltd.
The British United Provident Association Ltd. Life/Health InsuranceFinance The British United Provident Association Ltd. provides healthcare products and services. It offers health, dental and travel insurance, optical and audiology, and care homes. The company was founded on April 3, 1947 and is headquartered in London, the United Kingdom. | 1 years |
| Berndt A. E. Modig | M | 65 |
Shire Orphan Therapies GmbH
Shire Orphan Therapies GmbH Pharmaceuticals: MajorHealth Technology Shire Orphan Therapies GmbH engages in the development, manufacture, and distribution of chemical and biochemical products, ingredients, as well as pharmaceutical and diagnostic products. The company was founded in 1994 and is headquartered in Berlin, Germany. | 5 years |
| Sylvie Grégoire | M | 63 |
Shire Human Genetic Therapies, Inc.
Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | 6 years |
| Patrick J. Langlois | M | 78 | 6 years | |
| Jeff Miller | M | - | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 59 | 59.00% |
| United Kingdom | 16 | 16.00% |
| Netherlands | 12 | 12.00% |
| Ireland | 6 | 6.00% |
| Germany | 5 | 5.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Theresa Heggie
- Personal Network